CivaSheet is FDA cleared for the pancreatic cancer application. A multi-center NIH sponsored study is currently underway to investigate the benefits of CivaSheet for patients with pancreatic cancer. Virginia Commonwealth University in Richmond, VA, Fox Chase Cancer Center in Philadelphia, PA, Honor Health in Phoenix, Arizona, Rush Medical Center in Chicago, IL, Advocate Healthcare in Chicago, IL, and LSU in New Orleans, LA are currently recruiting patients.

For more information on clinical trials please visit the link below: